Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitis
- 31 January 1993
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 165 (1) , 40-45
- https://doi.org/10.1016/s0002-9610(05)80402-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Generation and Possible Significance of Trypsinogen Activation Peptides in Experimental Acute Pancreatitis in the RatPancreas, 1992
- A Better Model of Acute Pancreatitis for Evaluating TherapyAnnals of Surgery, 1992
- Gabexate Mesilate (FOY) Protects Against Ceruletide-Induced Acute Pancreatitis in the RatPancreas, 1987
- The Cell Biology of Experimental PancreatitisNew England Journal of Medicine, 1987
- Microangiography of the Pancreas in Experimental Oedemic and Haemorrhagic PancreatitisScandinavian Journal of Gastroenterology, 1986
- Experimental Pancreatitis in the RatEuropean Surgical Research, 1983
- Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the ratDigestive Diseases and Sciences, 1979
- Plasma Volume after Dextran Infusion in Rats Sensitive and Non-Sensitive to DextranEuropean Surgical Research, 1975
- Histological changes produced by experimental erythrocyte aggregationThe Journal of Pathology and Bacteriology, 1967
- The microcirculatory effects of dextranThe Journal of Pathology and Bacteriology, 1967